---

Fundamental Analysis of Health Net, Inc. (Historical Context)

Prior to its acquisition by Centene Corporation, Health Net, Inc. (HNT) was a managed care organization that provided health benefits through health plans and government-sponsored programs, with a significant presence in the Western United States, particularly California.

Fundamental Analysis of Health Net, Inc. (Historical Context)

The Acquisition by Centene Corporation (2016)

The definitive agreement for Centene to acquire Health Net was announced in July 2015 and the transaction closed in March 2016, valued at approximately $6.8 billion (including the assumption of debt).

Key Rationale and Strategic Benefits for Centene

The acquisition was a transformative move for Centene, fundamentally driven by strategic growth in government-sponsored healthcare programs:

• Market Leadership: The merger created the largest Medicaid Managed Care Organization in the U.S., significantly expanding Centene's scale.

• Geographic Expansion: It provided Centene with access to the lucrative California Medicaid program (the country's largest) and expanded its presence in other Western states like Arizona, Oregon, and Washington.

• Product Diversification: Health Net's high-quality Medicare platform, including its presence in Medicare Advantage, complemented Centene's core Medicaid focus, leading to a broader product portfolio, including contracts with the U.S. Department of Defense (TRICARE) and Veterans Affairs.

• Financial Synergy: Centene projected achieving approximately $150 million in annual cost synergies by the second year following the close, primarily from G&A efficiencies and leveraging integrated IT and specialty services.

Transaction Terms

Health Net shareholders received 0.622 shares of Centene common stock and $28.25 in cash for each share of Health Net common stock, effectively retiring the HNT ticker from the New York Stock Exchange.

---

Fundamental Analysis of Centene Corporation (CNC)

Since Health Net's operations are now part of Centene, a fundamental analysis must focus on the combined entity. Centene (CNC) is a diversified, multi-national healthcare enterprise that focuses on providing services to government-sponsored healthcare programs (Medicaid, Medicare, and the Health Insurance Marketplace).

1. Business Overview and Industry Position

Centene's core business revolves around managing health benefits for under-insured and uninsured individuals. Its major segments include:

• Medicaid: The largest segment, covering various state and federal programs (TANF, CHIP, Long-Term Services and Supports). The Health Net acquisition significantly bolstered its position here.

• Medicare: Includes Medicare Advantage plans and Medicare-Medicaid Plans (MMP).

• Commercial: Focuses on Health Insurance Marketplace (ACA Exchange) plans and commercial products.

The company operates in a highly regulated and competitive industry, where financial performance is closely tied to government policies, contract renewals, and healthcare utilization rates.

2. Financial Health and Performance (Based on Recent Trends)

Note: Specific financial figures are dynamic and would require the most recent quarterly or annual report for an up-to-date analysis. The following points highlight key areas for a fundamental review.

Revenue and Profitability

Centene has historically shown strong revenue growth, often fueled by acquisitions and expansion in government programs like Medicaid and the ACA Marketplace.

• Key Metric: Health Benefits Ratio (HBR): This is the ratio of medical costs paid to premium revenue. A lower HBR indicates higher profitability. Changes in government reimbursement rates or unexpected increases in healthcare utilization (e.g., post-pandemic demand) can significantly impact this ratio and, consequently, net margins.

• Net Income/Margins: Profitability can be volatile, influenced by regulatory changes, state contract wins/losses, and the costs associated with integrating large acquisitions like Health Net. Analysts look for management's ability to maintain or improve Net Profit Margins through operational efficiencies.

Balance Sheet and Liquidity

• Debt-to-Equity Ratio: Following major acquisitions, Centene's debt level can be significant. Fundamental analysis focuses on whether the company's Debt-to-Equity ratio is manageable and if its Interest Coverage Ratio (EBIT divided by Interest Expense) demonstrates a strong ability to service its debt obligations.

• Cash Flow: Free Cash Flow (FCF) is crucial, as it indicates the cash available to pay down debt, fund future growth, or potentially initiate a dividend. A strong FCF generation is a positive sign of operational efficiency.

3. Valuation Metrics

Analysts use various metrics to determine if Centene's stock is undervalued or overvalued:

• Price-to-Earnings (P/E) Ratio: Compares the current stock price to its earnings per share. In the healthcare sector, P/E ratios are often compared against industry peers (e.g., UnitedHealth Group, Elevance Health) and the company's historical average.

• Price-to-Sales (P/S) Ratio: Useful for high-revenue, lower-margin companies like managed care organizations. A low P/S ratio (typically less than 1) can indicate undervaluation relative to the market.

4. Growth Outlook and Risks

Growth Drivers

1. Medicaid/Medicare Expansion: Demographic shifts (aging population) and potential expansion of government programs continue to drive membership growth opportunities.

2. ACA Marketplace: Continued growth in the Health Insurance Marketplace is a significant driver, often carrying better margins than traditional Medicaid.

3. Strategic Divestitures: Centene has been actively divesting non-core assets to focus on its managed care business and improve capital structure.

Key Risks

1. Regulatory and Political Risk: Since a large portion of revenue comes from government contracts, changes in federal or state healthcare policy (e.g., Medicaid redeterminations, shifts in Medicare Advantage funding) pose a major risk.

2. Competition: The managed care industry is highly competitive, putting pressure on premium pricing and HBR.

3. Integration Risk: The ongoing integration of Health Net and other large acquisitions must be managed effectively to realize expected synergies and avoid operational disruption.

4. Medical Cost Inflation: Rising utilization and higher costs of healthcare services directly squeeze the company's margins.

Conclusion

Health Net, Inc.'s stock is no longer tradable. The legacy of the company now exists as an integrated part of Centene Corporation (CNC), primarily strengthening its position in the Western U.S. government-sponsored healthcare market. A fundamental analysis of CNC is necessary for investors, focusing on its dominant position in government programs, its ability to manage debt and operating costs in a highly regulated environment, and its valuation relative to its peers.